Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intapp, Inc. - Common Stock (NQ:INTA)

42.12 +0.65 (+1.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intapp, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Intapp to announce fiscal fourth quarter and year-end 2023 financial results on September 6, 2023
From Intapp Inc.
Via GlobeNewswire
Analyst Expectations for Intapp's Future
 
Via Benzinga
3 Stocks Signaling Confidence With Their Secondary Offerings
As the IPO market has heated up, so too have stocks with secondary offerings. Three of them stand out from the crowd. 
Via InvestorPlace
David Morton to join Intapp as Chief Financial Officer
From Intapp Inc.
Via GlobeNewswire
Analyst Expectations for Intapp's Future
 
Via Benzinga
Analyst Expectations for Intapp's Future
 
Via Benzinga
Piper Sandler Maintains Overweight Rating for Intapp: Here's What You Need To Know
 
Via Benzinga
The Latest Analyst Ratings for Intapp
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 10, 2023
 
Via Benzinga
3 Cloud Computing Stocks to Target for Triple-Digit Returns in 2023
Investors are largely focusing on AI, but sometimes in tech it's good to go back to basics with cloud computing stocks. 
Via InvestorPlace
Don’t Fall for It! 3 Overhyped Tech Stocks to Avoid
The rally this year has driven many stocks to unreasonably high levels, such as these three tech stocks to avoid. 
Via InvestorPlace
12 Information Technology Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
Intapp enhances DealCloud platform with access to M&A data from Bureau van Dijk, a Moody’s Analytics company
Native access to global M&A data enables investors and advisors to make better-informed and faster business development and deal decisions 
From Intapp Inc.
Via GlobeNewswire
DealCloud wins 2023 CRM Excellence Award from TMC
DealCloud chosen for its ability to cover the entire enterprise and lifetime of the client relationship 
From Intapp Inc.
Via GlobeNewswire
Intapp, Inc. to Participate in Upcoming Investor Conference
From Intapp Inc.
Via GlobeNewswire
Newly Public Intapp Well-Positioned For More Price Gains
Business software maker Intapp has a consensus "buy" rating and strong growth potential, despite recent price volatility due to a secondary stock offering. 
Via MarketBeat
Intapp partners with BoardEx to accelerate business development efforts with actionable relationship intelligence
New partnership enables professional and financial services firms to map relationship paths to 1.7 million executives worldwide from within the DealCloud platform 
From Intapp Inc.
Via GlobeNewswire
Asana Partners selects DealCloud for deal and relationship management
National real estate investment firm will deploy Intapp’s DealCloud platform to support capital markets, acquisition, and leasing teams 
From Intapp Inc.
Via GlobeNewswire
Intapp, Inc. to Participate in Upcoming Investor Conference
From Intapp Inc.
Via GlobeNewswire
Intapp Announces Pricing of Public Offering of Common Stock
From Intapp Inc.
Via GlobeNewswire
12 Information Technology Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Intapp Announces Proposed Public Offering of Common Stock
From Intapp Inc.
Via GlobeNewswire
12 Information Technology Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Zscaler To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Stifel raised the price target for XPO, Inc. (NYSE: XPO) from $48 to $51. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. XPO shares fell 1.5% to $47.72 in pre-market trading. 
Via Benzinga
Intapp Announces Third Quarter Fiscal Year 2023 Financial Results
From Intapp Inc.
Via GlobeNewswire
Intapp to announce fiscal third quarter 2023 financial results on May 8, 2023
From Intapp Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.